This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Introduction/Obsessive-Compulsive Disorder: The Hidden Epidemic

Eric Hollander, M.D.

Published: January 1, 1997

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

This supplement arises from a breakfast symposiumseries titled "OCD: New Perspectives and Practical Management" that took place at the American PsychiatricAssociation annual meeting in May 1996. It presents anoverview of obsessive-compulsive disorder (OCD) andexamples of related spectrum disorders and reviews somerecent research being done in pharmacologic and behaviortherapy, the two most successful types of therapy forOCD. In the papers that follow, Sasson and colleaguespresent a world view of OCD; Christopher J. McDouglediscusses pharmacologic treatment of refractory OCD;Flament and Bisserbe review some recent studies comparingSRI therapies; and Baer and Greist discuss the use ofbehavioral therapy in OCD patients, including an innovativepatient-initiated, telephone voice-activated behaviortherapy program.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 58

Quick Links: Obsessive-Compulsive and Related Disorders

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...